DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine effect on prostate cancer cell lines
Summary:
Analysis of prostate cancer cell lines after treatment with the DNA methyltransferase inhibitor 5-Aza-2'-deoxycytidine (5-aza-dC). Aberrant DNA methylation is an early event in the development of prostate cancer. Results identify hypermethylated genes whose expression is induced by 5-aza-dC.
Kim H, Lapointe J, Kaygusuz G, Ong DE et al. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 2005 Sep 15;65(18):8118-24. PMID: 16166285
